Publicaciones en las que colabora con LISARDO BOSCA GOMAR (40)

2023

  1. Beneficial effect of TLR4 blockade by a specific aptamer antagonist after acute myocardial infarction

    Biomedicine and Pharmacotherapy, Vol. 158

  2. Crosstalk between P2Y receptors and cyclooxygenase activity in inflammation and tissue repair

    Purinergic Signalling

  3. Lipoxin-mediated signaling: ALX/FPR2 interaction and beyond

    Pharmacological Research, Vol. 197

2022

  1. Functional Crosstalk between PCSK9 Internalization and Pro-Inflammatory Activation in Human Macrophages: Role of Reactive Oxygen Species Release

    International journal of molecular sciences, Vol. 23, Núm. 16

  2. Specialized Proresolving Mediators Protect Against Experimental Autoimmune Myocarditis by Modulating Ca2+ Handling and NRF2 Activation

    JACC: Basic to Translational Science, Vol. 7, Núm. 6, pp. 544-560

2021

  1. Resolution-Based Therapies: The Potential of Lipoxins to Treat Human Diseases

    Frontiers in Immunology, Vol. 12

2020

  1. BML-111 treatment prevents cardiac apoptosis and oxidative stress in a mouse model of autoimmune myocarditis

    FASEB Journal, Vol. 34, Núm. 8, pp. 10531-10546

  2. GRK2 levels in myeloid cells modulate adipose-liver crosstalk in high fat diet-induced obesity

    Cellular and Molecular Life Sciences, Vol. 77, Núm. 23, pp. 4957-4976

  3. Innate Immune Receptors, Key Actors in Cardiovascular Diseases

    JACC: Basic to Translational Science, Vol. 5, Núm. 7, pp. 735-749

2019

  1. Interplay between post-translational cyclooxygenase-2 modifications and the metabolic and proteomic profile in a colorectal cancer cohort

    World Journal of Gastroenterology, Vol. 25, Núm. 4, pp. 433-446

  2. Self-defense of macrophages against oxidative injury: Fighting for their own survival

    Redox Biology, Vol. 26

2018

  1. Deficiency of NOD1 improves the β-adrenergic modulation of Ca2+ handling in a mouse model of heart failure

    Frontiers in Physiology, Vol. 9, Núm. JUN

  2. GQ-11: A new PPAR agonist improves obesity-induced metabolic alterations in LDLr-/- mice

    International Journal of Obesity, Vol. 42, Núm. 5, pp. 1062-1072

  3. Post-translational modifications of prostaglandin-endoperoxide synthase 2 in colorectal cancer: An update

    World Journal of Gastroenterology, Vol. 24, Núm. 48, pp. 5454-5461

2017

  1. Mild and short-term caloric restriction prevents obesity-induced cardiomyopathy in young zucker rats without changing in metabolites and fatty acids cardiac profile

    Frontiers in Physiology, Vol. 8, Núm. FEB

  2. NOD1 activation in cardiac fibroblasts induces myocardial fibrosis in a murine model of type 2 diabetes

    Biochemical Journal, Vol. 474, Núm. 3, pp. 399-410

  3. Role of NOD1 in Heart Failure Progression via Regulation of Ca2+ Handling

    Journal of the American College of Cardiology, Vol. 69, Núm. 4, pp. 423-433

2016

  1. New PPARγ partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr -/- mice

    Pharmacological Research, Vol. 104, pp. 49-60

  2. Cell expansion-dependent inflammatory and metabolic profile of human bone marrow mesenchymal stem cells

    Frontiers in Physiology, Vol. 7, Núm. NOV

2015

  1. A labdane diterpene exerts ex vivo and in vivo cardioprotection against post-ischemic injury: Involvement of AKT-dependent mechanisms

    Biochemical Pharmacology, Vol. 93, Núm. 4, pp. 428-439